- Home
- CUE vs NHTC Comparison
CUE vs NHTC Comparison
Compare CUE & NHTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- NHTC
- Stock Information
- Founded
- CUE 2014
- NHTC 1988
- Country
- CUE United States
- NHTC United States
- Employees
- CUE N/A
- NHTC N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- NHTC Diversified Commercial Services
- Sector
- CUE Health Care
- NHTC Miscellaneous
- Exchange
- CUE Nasdaq
- NHTC Nasdaq
- Market Cap
- CUE 56.1M
- NHTC 56.0M
- IPO Year
- CUE 2018
- NHTC 1995
- Fundamental
- Price
- CUE $0.86
- NHTC N/A
- Analyst Decision
- CUE Strong Buy
- NHTC
- Analyst Count
- CUE 2
- NHTC 0
- Target Price
- CUE $3.00
- NHTC N/A
- AVG Volume (30 Days)
- CUE 220.6K
- NHTC 15.4K
- Earning Date
- CUE 11-13-2025
- NHTC 10-29-2025
- Dividend Yield
- CUE N/A
- NHTC 18.61%
- EPS Growth
- CUE N/A
- NHTC N/A
- EPS
- CUE N/A
- NHTC 0.03
- Revenue
- CUE $8,286,000.00
- NHTC $42,087,000.00
- Revenue This Year
- CUE N/A
- NHTC N/A
- Revenue Next Year
- CUE N/A
- NHTC N/A
- P/E Ratio
- CUE N/A
- NHTC $140.29
- Revenue Growth
- CUE N/A
- NHTC N/A
- 52 Week Low
- CUE $0.54
- NHTC $4.02
- 52 Week High
- CUE $1.99
- NHTC $6.79
- Technical
- Relative Strength Index (RSI)
- CUE 58.69
- NHTC 39.90
- Support Level
- CUE $0.71
- NHTC $4.21
- Resistance Level
- CUE $0.73
- NHTC $4.45
- Average True Range (ATR)
- CUE 0.04
- NHTC 0.12
- MACD
- CUE 0.01
- NHTC -0.02
- Stochastic Oscillator
- CUE 95.92
- NHTC 16.86
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.